Not Yet Recruiting OBSERVATIONAL NCT07093775

Additional Prognostic Value of Tumor Grade Beyond the 21-gene Recurrence Score

Prognostic Implication of Tumor Grade in Patients With Node-negative Breast Cancer Aged ≤ 50 Years With 21-gene Recurrence Scores of 11-25

Sponsor: Gangnam Severance Hospital

Conditions Breast Cancer Tumor Grade

Interventions Tumor grade (I or II vs. III)

Updated 1 time since 2025 Last updated: Jul 22, 2025 Started: Jul 31, 2025 Primary completion: Dec 31, 2025 Completion: Mar 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07093775, this observational or N/A phase trial focuses on Breast Cancer and Tumor Grade and remains actively recruiting participants. Sponsored by Gangnam Severance Hospital, it has been updated 1 time since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

1 version recorded

Not Yet Recruiting [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gangnam Severance Hospital

Data source: Gangnam Severance Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.